VTA µ-Opioidergic Neurons Facilitate Low Sociability in Protracted Opioid Abstinence
Opioids initiate dynamic maladaptation in brain reward and affect circuits that occur throughout chronic exposure and withdrawal that persist beyond cessation. Protracted abstinence is characterized by negative affective behaviors such as heightened anxiety, irritability, dysphoria, and anhedonia, which pose a significant risk factor for relapse. While the ventral tegmental area (VTA) and μ-opioid receptors (MORs) are critical for opioid reinforcement, the specific contributions of VTA<sup>MOR</sup> neurons in mediating protracted abstinence-induced negative affect is not fully understood. In our study, we elucidate the role of VTA<sup>MOR</sup> neurons in mediating negative affect and altered brain-wide neuronal activities following forced opioid exposure and abstinence in male and female mice. Utilizing a chronic oral morphine administration model, we observe increased social deficit, anxiety-related, and despair-like behaviors during protracted forced abstinence. VTA<sup>MOR</sup> neurons show heightened neuronal FOS activation at the onset of withdrawal and connect to an array of brain regions that mediate reward and affective processes. Viral re-expression of MORs selectively within the VTA of MOR knock-out mice demonstrates that the disrupted social interaction observed during protracted abstinence is facilitated by this neural population, without affecting other protracted abstinence behaviors. Lastly, VTA<sup>MORs</sup> contribute to heightened neuronal FOS activation in the anterior cingulate cortex (ACC) in response to an acute morphine challenge, suggesting their unique role in modulating ACC-specific neuronal activity. These findings identify VTA<sup>MOR</sup> neurons as critical modulators of low sociability during protracted abstinence and highlight their potential as a mechanistic target to alleviate negative affective behaviors associated with opioid abstinence.
Authors
- Yihan Xie (ORCID: https://orcid.org/0009-0002-3084-3204)
- Kate Townsend Creasy (ORCID: https://orcid.org/0000-0003-1870-4586)
- Julie A. Blendy (ORCID: https://orcid.org/0000-0003-1705-9001)
- Adrienne Jo
- Blake A. Kimmey (ORCID: https://orcid.org/0000-0001-6559-8005)
- Sophie A. Rogers
- Lisa M. Wooldridge (ORCID: https://orcid.org/0000-0001-6465-1222)
- R. Ortega (ORCID: https://orcid.org/0000-0002-6449-7883)
- Kevin T. Beier (ORCID: https://orcid.org/0000-0002-4934-1338)
- Gregory Corder (ORCID: https://orcid.org/0000-0003-0031-0773)
- Amrith Rodrigues
Institutions
- Neurosciences Institute (US)
- University of California, Irvine (US)
- Neurobehavioral Systems (US)
- Translational Therapeutics (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Neuroscience
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1523/jneurosci.1154-24.2025
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Pennsylvania
- National Institutes of Health
- National Institute of General Medical Sciences